| << Back |
| IntegraMed America to Hold Fourth Quarter and Year 2002 Financial Results Conference Call February 20, 2003 |
| PURCHASE, N.Y., Feb 12, 2003 (BUSINESS WIRE) -- IntegraMed America, Inc.
(Nasdaq: INMD) today announced that the Company will release fourth quarter and
year 2002 financial results on Wednesday, February 19, 2003, after the close of
the financial markets.
Gerardo Canet, president and chief executive officer, and John Hlywak, Jr., chief financial officer, will host an investment-community conference call beginning Thursday, February 20, 2003, at 10:00 a.m. Eastern Time to discuss those results and to answer questions. It is anticipated that other Senior officers of the Company will also participate in the call. To participate in the live call via telephone, please call (888) 803-7481 (domestic) or (706) 634-1308 (international). A telephone replay will be available through 12:00 p.m. Eastern Time, February 24 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering reservation number 8334179. Individuals interested in listening to the conference call via the Internet may do so by visiting the Company's web site at www.integramed.com. A replay will be available on the web site for 14 days. IntegraMed America, based in Purchase, N.Y., is focused on the $2 billion infertility industry, and offers products and services to patients, providers, payers and manufacturers. Specifically, the Company provides Business Services to a network of Fertility Centers; distributes pharmaceutical products and financing programs directly to patients; operates www.integramed.com, an award-winning infertility Web site; and conducts clinical research through IntegraMed Research Institute. Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed America are forward-looking statements. Actual results may differ materially from the statements made as a result of various factors including, but not limited to, the risks associated with the Company's ability to finance future growth; the loss of significant management contract(s); profitability at Reproductive Science Centers managed by IntegraMed America; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the Company's most recent Form 10-K and in other documents filed by the Company with the U.S. Securities and Exchange Commission (SEC).
CONTACT: |
| "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding IntegraMed America, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year. |